| Literature DB >> 31849825 |
Peicong Ge1,2,3,4,5, Xun Ye1,2,3,4,5, Xingju Liu1,2,3,4,5, Xiaofeng Deng1,2,3,4,5, Jia Wang1,2,3,4,5, Rong Wang1,2,3,4,5, Yan Zhang1,2,3,4,5, Dong Zhang1,2,3,4,5, Qian Zhang1,2,3,4,5, Jizong Zhao1,2,3,4,5.
Abstract
Objective: To identify associated risk factors for the angiographic outcomes after direct and combined bypass surgery in moyamoya disease (MMD).Entities:
Keywords: bypass patency; direct and combined bypass; moyamoya disease; postoperative collateral formation; risk factors
Year: 2019 PMID: 31849825 PMCID: PMC6903770 DOI: 10.3389/fneur.2019.01267
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1(A) Normal: normal AChA. (B) Dilated: dilated AChA with distal branching or abnormal branches. (C) Negative: normal or dilated PComA. (D) Positive: dilated PComA with abnormal branch extensions.
Figure 2Patency of the anastomosis. (A) Occluded: complete proximal occlusion of STA and disappearance of MCA branches. (B) Stenosed: thin and stenosed STA with a few visible MCA branches. (C) Patent: patent or dilated STA with patent or even dilated MCA branches.
Figure 3Postoperative collateral formation was evaluated with the Matsushima scale. (A) Level A: more than 2/3 of the MCA distribution. (B) Level B: between 2/3 and 1/3 of the MCA distribution. (C) Level C: slight or none.
Clinical characteristics of 188 hemispheres in this study.
| Hemispheres | 188 |
| Female/male ratio | 1.2:1.0 (103/85) |
| Age at operation, median (IQR), y | 34.5 (24.25–43.0) |
| Age | |
| <18 years | 30 (16.0%) |
| Hypertension | 47 (25.0%) |
| Smoking | 14 (7.4%) |
| Diabetes | 8 (4.3%) |
| Alcohol use | 9 (4.8%) |
| Hyperlipidemia | 6 (3.2%) |
| Thyroid disease | 2 (1.1%) |
| Infarction | 70 (37.2%) |
| Hemorrhage | 51 (27.1%) |
| TIA | 42 (22.3%) |
| Frequent TIAs | 9 (4.8%) |
| Headache | 11 (5.9%) |
| Seizures | 4 (2.1%) |
| No symptom | 1 (0.5%) |
| mRS >2 at admission | 133 (70.7%) |
| I | 2 (1.1%) |
| II | 29 (15.4%) |
| III | 73 (38.8%) |
| IV | 55 (29.3%) |
| V | 26 (13.8%) |
| VI | 3 (1.6%) |
| PCA involved | 62 (33.0%) |
| AChA dilated | 70 (37.2%) |
| PComA positive | 19 (10.1%) |
| DB | 80 (42.6%) |
| DB+EDS | 75 (39.9%) |
| DB+EDAS | 33 (17.6%) |
| Normal | 6 (3.3%) |
| Stage I | 7 (3.8%) |
| Stage II | 39 (21.3%) |
| Stage III | 84 (45.9%) |
| Stage IV | 47 (25.7%) |
| DSA follow-up, median (IQR), mons | 18 (12-35) |
183 hemispheres received CTP.
AChA, anterior choroidal artery; DB, direct bypass; DB+EDS, direct bypass and encephalodurosynangiosis; DB+EDAS, direct bypass and encephaloduroarteriosynangiosis; DSA, digital substraction angiography; IQR, interquartile range; mRS, modified Rankin Scale; PCA, posterior cerebral artery; PComA, posterior communicating artery; TIA, transient ischemic attack.
Angiographic outcomes.
| Bypass patency | <0.001 | ||||
| Occluded | 22 (11.7%) | 0 (0.0%) | 2 (3.6%) | 20 (31.7%) | |
| Stenosed | 34 (18.1%) | 2 (2.9%) | 7 (12.5%) | 25 (39.7%) | |
| Patent | 132 (70.2%) | 67 (97.1%) | 47 (83.9%) | 18 (28.6%) | |
Goodman-Kruskal Gamma test, Gamma = 0.891.
Logistic regression analysis of predictors for bypass patency.
| <35 | 24 (18.2%) | 6 (10.7%) | 0.339 | ||
| ≥35 | 108 (81.8%) | 50 (89.3%) | |||
| Female sex | 70 (53%) | 33 (58.9%) | 0.590 | ||
| Hypertension | 34 (25.8%) | 13 (23.2%) | 0.069 | ||
| Smoking | 10 (7.6%) | 4 (7.1%) | 0.918 | ||
| Diabetes | 6 (4.5%) | 2 (3.6%) | 0.215 | ||
| Alcohol use | 8 (6.1%) | 1 (1.8%) | 0.613 | ||
| Hyperlipidemia | 4 (3.0%) | 2 (3.6%) | 0.485 | ||
| Thyroid disease | 2 (1.5%) | 0 (0.0%) | 0.999 | ||
| Hemorrhage | 28 (21.2%) | 23 (41.1%) | 0.298 (0.125–0.709) | ||
| Infarction | 51 (38.6%) | 19 (33.9%) | 0.394 | 0.367 | 0.684 (0.299–1.563) |
| Others | 53 (40.2%) | 14 (25.0%) | |||
| Suzuki stage | 0.164 | ||||
| I | 0 (1.5%) | 0 (0.0%) | |||
| II | 3 (12.9%) | 12 (21.4%) | |||
| III | 10 (42.4%) | 17 (30.4%) | |||
| IV | 10 (29.5%) | 16 (28.6%) | |||
| V | 1 (12.1%) | 10 (17.9%) | |||
| VI | 0 (1.5%) | 1 (1.8%) | |||
| AChA dilated | 12 (34.1%) | 25 (44.6%) | 0.172 | ||
| PComA positive | 3 (8.3%) | 8 (14.3%) | 0.227 | ||
| PCA involved | 9 (31.1%) | 21 (37.5%) | 0.604 | ||
| The stage of preinfarction period | 0.062 | 1.379 (0.984–1.932) | |||
| Normal | 2 (1.6%) | 4 (7.3%) | |||
| Stage I | 4 (3.1%) | 3 (5.5%) | |||
| Stage II | 26 (20.3%) | 13 (23.6%) | |||
| Stage III | 61 (47.7%) | 23 (41.8%) | |||
| Stage IV | 35 (27.3%) | 12 (21.8%) | |||
| DB+EDAS | 22 (16.7%) | 11 (19.6%) | 0.368 | 0.096 | 0.447 (0.174–1.152) |
| DB+EDS | 50 (37.9%) | 25 (44.6%) | 0.255 | 0.155 | 0.584 (0.279–1.346) |
| DB | 60 (45.5%) | 20 (35.7%) | |||
Adjusted for surgical modalities. One hundred and eighty-three hemispheres received CTP. Boldface indicates statistical significance (p <0.05).
AChA, anterior choroidal artery; DB, direct bypass; DB+EDS, direct bypass and encephalodurosynangiosis; DB+EDAS, direct bypass and encephaloduroarteriosynangiosis; CI, confidence intervals; OR, odds ratios; PCA, posterior cerebral artery; PComA, posterior communicating artery.
Logistic regression analysis of predictors for postoperative collateral formation.
| <35 | 71 (56.8%) | 23 (36.5%) | 2.396 (1.231–4.664) | ||
| ≥35 | 54 (43.2%) | 40 (63.5%) | |||
| Female sex | 70 (56.0%) | 33 (52.4%) | 0.638 | ||
| Hypertension | 29 (23.2%) | 18 (28.6%) | 0.183 | ||
| Smoking | 9 (7.2%) | 5 (7.9%) | 0.444 | ||
| Diabetes | 6 (4.8%) | 2 (3.2%) | 0.322 | ||
| Alcohol use | 7 (5.6%) | 2 (3.2%) | 0.480 | ||
| Hyperlipidemia | 3 (2.4%) | 3 (3.2%) | 0.391 | ||
| Thyroid disease | 2 (1.6%) | 0 (0.0%) | 0.626 | ||
| Hemorrhage | 26 (20.8%) | 25 (39.7%) | 0.329 (0.143–0.758) | ||
| Infarction | 47 (37.6%) | 23 (36.5%) | 0.173 | 0.226 | 0.609 (0.273–1.359) |
| Others | 52 (41.6%) | 15 (23.8%) | |||
| Suzuki stage | 0.584 | ||||
| I | 2 (1.6%) | 0 (0.0%) | |||
| II | 16 (12.8%) | 13 (20.6%) | |||
| III | 51 (40.8%) | 22 (34.9%) | |||
| IV | 41 (32.8%) | 14 (22.2%) | |||
| V | 14 (11.2%) | 12 (19.0%) | |||
| VI | 1 (0.8%) | 2 (3.2%) | |||
| PCA involved | 43 (34.4%) | 19 (30.2%) | 0.941 | ||
| AChA dilated | 40 (32.0%) | 30 (47.6%) | 0.472 (0.240–0.929) | ||
| PComA positive | 9 (7.2%) | 10 (15.9%) | 0.072 | ||
| The stage of preinfarction period | 0.438 | ||||
| Normal | 2 (1.7%) | 4 (6.3%) | |||
| Stage I | 4 (3.3%) | 3 (4.8%) | |||
| Stage II | 26 (21.7%) | 13 (20.6%) | |||
| Stage III | 59 (49.2%) | 25 (39.7%) | |||
| Stage IV | 29 (24.2%) | 18 (28.6%) | |||
| DB+EDAS | 23 (18.4%) | 10 (15.9%) | 0.921 | 0.387 | 0.655 (0.251–1.709) |
| DB+EDS | 47 (37.6%) | 28 (44.4%) | 0.425 | 0.180 | 0.611 (0.298–1.254) |
| DB | 55 (44.0%) | 25 (39.7%) | |||
Adjusted for surgical modalities. One hundred and eighty-three hemispheres received CTP. Boldface indicates statistical significance (p <0.05).
AChA, anterior choroidal artery; DB, direct bypass; DB+EDS, direct bypass and encephalodurosynangiosis; DB+EDAS, direct bypass and encephaloduroarteriosynangiosis; CI, confidence intervals; OR, odds ratios; PCA, posterior cerebral artery; PCF, postoperative collateral formation; PComA, posterior communicating artery.